TP53 and urinary bladder carcinoma: Moreover, casticin increases p-p53, H2A.X variant histone, and poly-ADP ribose polymerase (PARP) levels, and affects phospho-p53 translocation from the cytoplasm to the nucleus in bladder cancer cells (24).